- Home
- ZKIN vs MBRX Comparison
ZKIN vs MBRX Comparison
Compare ZKIN & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZKIN
- MBRX
- Stock Information
- Founded
- ZKIN 2015
- MBRX 2015
- Country
- ZKIN China
- MBRX United States
- Employees
- ZKIN N/A
- MBRX N/A
- Industry
- ZKIN Metal Fabrications
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- ZKIN Industrials
- MBRX Health Care
- Exchange
- ZKIN Nasdaq
- MBRX Nasdaq
- Market Cap
- ZKIN 12.6M
- MBRX 14.7M
- IPO Year
- ZKIN 2017
- MBRX 2016
- Fundamental
- Price
- ZKIN $2.35
- MBRX $0.67
- Analyst Decision
- ZKIN
- MBRX Strong Buy
- Analyst Count
- ZKIN 0
- MBRX 2
- Target Price
- ZKIN N/A
- MBRX $6.00
- AVG Volume (30 Days)
- ZKIN 6.5M
- MBRX 1.0M
- Earning Date
- ZKIN 01-01-0001
- MBRX 05-13-2025
- Dividend Yield
- ZKIN N/A
- MBRX N/A
- EPS Growth
- ZKIN N/A
- MBRX N/A
- EPS
- ZKIN N/A
- MBRX N/A
- Revenue
- ZKIN $108,199,877.00
- MBRX N/A
- Revenue This Year
- ZKIN N/A
- MBRX N/A
- Revenue Next Year
- ZKIN N/A
- MBRX N/A
- P/E Ratio
- ZKIN N/A
- MBRX N/A
- Revenue Growth
- ZKIN N/A
- MBRX N/A
- 52 Week Low
- ZKIN $0.82
- MBRX $0.40
- 52 Week High
- ZKIN $6.30
- MBRX $4.90
- Technical
- Relative Strength Index (RSI)
- ZKIN 51.17
- MBRX 29.72
- Support Level
- ZKIN $2.21
- MBRX $0.62
- Resistance Level
- ZKIN $2.47
- MBRX $0.93
- Average True Range (ATR)
- ZKIN 0.32
- MBRX 0.07
- MACD
- ZKIN -0.10
- MBRX -0.03
- Stochastic Oscillator
- ZKIN 13.49
- MBRX 14.06
About ZKIN ZK International Group Co. Ltd
ZK International Group Co Ltd is engaged in the manufacture and marketing of metal pipes. The company is specialized in producing double-press thin-walled stainless steel tubes and fittings, carbon steel tubes and fittings, single-press tubes and fittings, and stainless-steel strips. The products are used in restaurants, hotels, hospitals, firefighting, food, beverage, ships, engines, industrial seawater desalination and systems of direct-drinking water, cold /hot water supply, city water supply, and gas of large/middle scale construction projects.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.